Transactivator Protein BICP0 of Bovine Herpesvirus 1 (BHV-1) Is Blocked by Prostaglandin D2 (PGD2), Which Points to a Mechanism for PGD2-Mediated Inhibition of BHV-1 Replication

Journal of Virology

Volumn 78, Issue 8, 2004, Pages 3805-3810

  Saydam, Okay ^a   Abril, Carlos ^a   Vogt, Bernd ^a   Ackermann, Mathias ^a   Schwyzer, Martin ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; COMPLEMENTARY DNA; IMMEDIATE EARLY PROTEIN; LIPOCALIN; PROSTAGLANDIN D SYNTHASE; PROSTAGLANDIN D2; PROTEIN BICPO; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA LIBRARY; DRUG ACTIVITY; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TRANSACTIVATION; TWO HYBRID SYSTEM; VIRUS GENE; VIRUS INHIBITION; VIRUS REPLICATION; WILD TYPE;

ANIMALS; BASE SEQUENCE; CATTLE; CELL LINE; DNA, VIRAL; HELA CELLS; HERPESVIRUS 1, BOVINE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; PROSTAGLANDIN D2; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITIN-PROTEIN LIGASES; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 1842536999     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.8.3805-3810.2004     Document Type: Article

References (57)

1. Baker, D. A., J. Thomas, J. Epstein, D. Possilico, and M. L. Stone. 1982. The effect of prostaglandins on the multiplication and cell-to-cell spread of herpes simplex virus type 2 in vitro. Am. J. Obstet. Gynecol. 144:346-349.
2. Bartel, P., C. T. Chien, R. Sternglanz, and S. Fields. 1993. Elimination of false positives that arise in using the two-hybrid system. BioTechniques 14:920-924.
3. Breyer, R. M., C. K. Bagdassarian, S. A. Myers, and M. D. Breyer. 2001. Prostanoid receptors: subtypes and signaling. Annu. Rev. Pharmacol. Toxicol. 41:661-690.
4. Calderwood, S. K., B. Bornstein, E. K. Farnum, and M. A. Stevenson. 1989. Heat shock stimulates the release of arachidonic acid and the synthesis of prostaglandins and leukotriene B4 in mammalian cells. J. Cell. Physiol. 141:325-333.
5. Coffman, T. M., B. H. Koller, and S. L. Tilley. 2001. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Investig. 108:15-23.
6. Dussault, I., and B. M. Forman. 2000. Prostaglandins and fatty acids regulate transcriptional signaling via the peroxisome proliferator activated receptor nuclear receptors. Prostaglandins Other Lipid Mediat. 62:1-13.
7. Edes, K., F. A. Fitzpatrick, and P. J. Moos. 2000. Inactivation of wild-type p53 tumor suppressor by electrophilic prostaglandins. Proc. Natl. Acad. Sci. USA 97:9215-9220.
8. Everett, R. D. 1988. Analysis of the functional domains of herpes simplex virus type 1 immediate-early polypeptide Vmw110. J. Mol. Biol. 202:87-96.
9. Everett, R. D. 2000. ICP0, a regulator of herpes simplex virus during lytic and latent infection. Bioessays 22:761-770.
10. Everett, R. D., M. Meredith, A. Orr, A. Cross, M. Kathoria, and J. Parkinson. 1997. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J. 16:1519-1530.
11. Fraefel, C., M. Ackermann, and M. Schwyzer. 1994. Identification of the bovine herpesvirus 1 Circ protein, a myristylated and virion-associated polypeptide which is not essential for virus replication in cell culture. J. Virol. 68:8082-8088.
12. Fraefel, C., J. Zeng, Y. Choffat, M. Engels, M. Schwyzer, and M. Ackermann. 1994. Identification and zinc dependence of the bovine herpesvirus 1 transactivator protein BICP0. J. Virol. 68:3154-3162.
13. Funk, C. D. 2001. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294:1871-1875.
14. Gerozissis, K., P. Jouannet, J. C. Soufir, and F. Dray. 1982. Origin of prostaglandins in human semen. J. Reprod. Fertil. 65:401-404.
15. Gietz, R. D., R. H. Schiestl, A. R. Willems, and R. A. Woods. 1995. Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. Yeast 11:355-360.
16. 2 system. J. Appl. Physiol. 92:863-868.
17. Hayaishi, O. 2000. Molecular mechanisms of sleep-wake regulation: a role of prostaglandin D2. Philos. Trans. R. Soc. Lond. B Biol. Sci. 355:275-280.
18. Hayaishi, O., and Y. Urade. 2002. Prostaglandin D2 in sleep-wake regulation: recent progress and perspectives. Neuroscientist 8:12-15.
19. Herschman, H. R., S. T. Reddy, and W. Xie. 1997. Function and regulation of prostaglandin synthase-2. Adv. Exp. Med. Biol. 407:61-66.
20. Higaki, S., B. M. Gebhardt, W. J. Lukiw, H. W. Thompson, and J. M. Hill. 2002. Effect of immunosuppression on gene expression in the HSV-1 latently infected mouse trigeminal ganglion. Investig. Ophthalmol. Vis. Sci. 43:1862-1869.
21. Hill, J. M., W. J. Lukiw, B. M. Gebhardt, S. Higaki, J. M. Loutsch, M. E. Myles, H. W. Thompson, B. S. Kwon, N. G. Bazan, and H. E. Kaufman. 2001. Gene expression analyzed by microarrays in HSV-1 latent mouse trigeminal ganglion following heat stress. Virus Genes 23:273-280.
22. Hoffman, C. S., and F. Winston. 1987. A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene 57:267-272.
23. Hüssy, D., N. Stäuber, C. M. Leutenegger, S. Rieder, and M. Ackermann. 2001. Quantitative fluorogenic PCR assay for measuring ovine herpesvirus 2 replication in sheep. Clin. Diagn. Lab. Immunol. 8:123-128.
24. Kawaguchi, Y., R. Bruni, and B. Roizman. 1997. Interaction of herpes simplex virus 1 alpha regulatory protein ICP0 with elongation factor 1delta: ICP0 affects translational machinery. J. Virol. 71:1019-1024.
25. Kawaguchi, Y., C. Van Sant, and B. Roizman. 1997. Herpes simplex virus 1 alpha regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3. J. Virol. 71:7328-7336.
26. Köppel, R., C. Fraefel, B. Vogt, L. J. Bello, W. C. Lawrence, and M. Schwyzer. 1996. Recombinant bovine herpesvirus-1 (BHV-1) lacking transactivator protein BICP0 entails lack of glycoprotein C and severely reduced infectivity. Biol. Chem. 377:787-795.
27. Köppel, R., B. Vogt, and M. Schwyzer. 1997. Immediate-early protein BICP22 of bovine herpesvirus 1 trans-represses viral promoters of different kinetic classes and is itself regulated by BICP0 at transcriptional and posttranscriptional levels. Arch. Virol. 142:2447-2464.
28. Leung, D. Y., L. Key, J. J. Steinberg, M. C. Young, M. Von Deck, R. Wilkinson, and R. S. Geha. 1988. Increased in vitro bone resorption by monocytes in the hyper-immunoglobulin E syndrome. J. Immunol. 140:84-88.
29. Meredith, M., A. Orr, and R. Everett. 1994. Herpes simplex virus type 1 immediate-early protein Vmw110 binds strongly and specifically to a 135-kDa cellular protein. Virology 200:457-469.
30. Metzler, A. E., A. A. Schudel, and M. Engels. 1986. Bovine herpesvirus 1: molecular and antigenic characteristics of variant viruses isolated from calves with neurological disease. Arch. Virol. 87:205-217.
31. Moriuchi, M., H. Inoue, and H. Moriuchi. 2001. Reciprocal interactions between human T-lymphotropic virus type 1 and prostaglandins: implications for viral transmission. J. Virol. 75:192-198.
32. Narumiya, S., T. Ogorochi, K. Nakao, and O. Hayaishi. 1982. Prostaglandin D2 in rat brain, spinal cord and pituitary: basal level and regional distribution. Life Sci. 31:2093-2103.
33. Narumiya, S., Y. Sugimoto, and F. Ushikubi. 1999. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79:1193-1226.
34. 2 levels as a predictor of periodontal attachment loss. J. Periodontal Res. 21:101-112.
35. Ogorochi, T., S. Narumiya, N. Mizuno, K. Yamashita, H. Miyazaki, and O. Hayaishi. 1984. Regional distribution of prostaglandins D2, E2, and F2 alpha and related enzymes in postmortem human brain. J. Neurochem. 43:71-82.
36. Pascual, G., M. Li, J. S. Welch, M. Ricote, C. H. Hsiang, L. L. Sengchanthalangsy, G. Ghosh, C. K. Glass, and D. S. Straus. 2000. 15-Deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway. Proc. Natl. Acad. Sci. USA 97:4844-4849.
37. Petersen, G. M., A. J. Krush, S. Booker, J. Jen, F. M. Giardiello, S. R. Hamilton, B. Vogelstein, K. W. Kinzler, and W. S. el-Deiry. 1993. WAF1, a potential mediator of p53 tumor suppression. N. Engl. J. Med. 329:1982-1987.
38. Pica, F., A. De Marco, F. De Cesare, and M. G. Santoro. 1993. Inhibition of vesicular stomatitis virus replication by delta 12-prostaglandin J2 is regulated at two separate levels and is associated with induction of stress protein synthesis. Antivir. Res. 20:193-208.
39. 2 is a potent inhibitor of influenza A virus replication. Antimicrob. Agents Chemother. 44:200-204.
40. Quayle, A. J., R. W. Kelly, T. B. Hargreave, and K. James. 1989. Immunosuppression by seminal prostaglandins. Clin. Exp. Immunol. 75:387-391.
41. Rossi, A., P. Kapahi, G. Natoli, T. Takahashi, Y. Chen, M. Karin, and M. G. Santoro. 2000. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase. Nature 403:103-108.
42. Santoro, M. G. 1997. Antiviral activity of cyclopentenone prostanoids. Trends Microbiol. 5:276-281.
43. Santoro, M. G., C. Amici, G. Elia, A. Benedetto, and E. Garaci. 1989. Inhibition of virus protein glycosylation as the mechanism of the antiviral action of prostaglandin A in Sendai virus-infected cells. J. Gen. Virol. 70:789-800.
44. Santoro, M. G., A. Benedetto, S. Zaniratti, E. Garaci, and B. M. Jaffe. 1983. The relationship between prostaglandins and virus replication: endogenous prostaglandin synthesis during infection and the effect of exogenous PGA on virus production in different cell lines and in persistently infected cells. Prostaglandins 25:353-364.
45. Santoro, M. G., M. Fukushima, A. Benedetto, and C. Amici. 1987. PGJ2, a new antiviral prostaglandin: inhibition of Sendai virus replication and alteration of virus protein synthesis. J. Gen. Virol. 68:1153-1158.
46. Santoro, M. G., B. M. Jaffe, and M. Esteban. 1983. Prostaglandin A inhibits the replication of vesicular stomatitis virus: effect on virus glycoprotein. J. Gen. Virol. 64:2797-2801.
47. Saydam, O., B. Vogt, M. Ackermann, and M. Schwyzer. 2002. Search for physical interaction between BICP0 of bovine herpesvirus-1 and p53 tumor suppressor protein. Vet. Microbiol. 86:95-102.
48. Schwyzer, M., U. V. Wirth, B. Vogt, and C. Fraefel. 1994. BICP22 of bovine herpesvirus 1 is encoded by a spliced 1.7-kb RNA which exhibits immediate-early and late transcription kinetics. J. Gen. Virol. 75:1703-1711.
49. Serhan, C. N., J. Z. Haeggstrom, and C. C. Leslie. 1996. Lipid mediator networks in cell signaling: update and impact of cytokines. FASEB J. 10:1147-1158.
50. Urade, Y., and O. Hayaishi. 2000. Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase. Biochim. Biophys. Acta 1482:259-271.
51. 2 and sleep regulation. Biochim. Biophys. Acta 1436:606-615.
52. Urade, Y., and O. Hayaishi. 2000. Prostaglandin D synthase: structure and function. Vitam. Horm. 58:89-120.
53. Urade, Y., K. Watanabe, and O. Hayaishi. 1995, Prostaglandin D, E, and F synthases. J. Lipid Mediat. Cell Signal 12:257-273.
54. Versteeg, H. H., P. M. van Bergen en Henegouwen, S. J. van Deventer, and M. P. Peppelenbosch. 1999. Cyclooxygenase-dependent signalling: molecular events and consequences. FEBS Lett. 445:1-5.
55. Wirth, U. V., C. Fraefel, B. Vogt, C. Vlcek, V. Paces, and M. Schwyzer. 1992. Immediate-early RNA 2.9 and early RNA 2.6 of bovine herpesvirus 1 are 3′ coterminal and encode a putative zinc finger transactivator protein. J. Virol. 66:2763-2772.
56. Ye, Q., and H. J. Worman. 1995. Protein-protein interactions between human nuclear lamins expressed in yeast. Exp. Cell Res. 219:292-298.
57. Zhang, Y., and C. Jones. 2001. The bovine herpesvirus 1 immediate-early protein (bICP0) associates with histone deacetylase 1 to activate transcription. J. Virol. 75:9571-9578.